Physician profile
Jason Chouake
NPI 1891135943
$1,729.72
in general payments reported to CMS, 2019-2025
16 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.32 · 2020: $11.50 · 2021: $14.28 · 2022: $142 · 2023: $200 · 2024: $205 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $351.95 | 2024-2025 | |
| Abbvie INC. | $251.06 | 2022-2025 | Rinvoq, Skyrizi |
| Pfizer INC. | $205.45 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $193.23 | 2024-2025 | Dupixent |
| Janssen Biotech, INC. | $168.73 | 2022-2025 | Tremfya, Stelara, Simponi |
| Incyte Corporation | $168.09 | 2023-2025 | Opzelura |
| Ucb, INC. | $92.50 | 2024-2025 | Bimzelx |
| Amgen INC. | $85.43 | 2025 | Otezla, Otezla |
| Genzyme Corporation | $48.59 | 2025 | |
| Lilly USA, LLC | $47.39 | 2022 | |
| Allergan, INC. | $37.93 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $19.13 | 2023 | |
| Novartis Pharmaceuticals Corporation | $18.54 | 2022 | |
| Leo Pharma INC. | $15.92 | 2022 | |
| Glaxosmithkline, LLC. | $14.28 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Chouake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.